title: Neutrophil to lymphocyte ratio: another drop in the ocean of CRPC biomakers?
authors: Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid; Centro Integral Oncológico Clara Campal (CIOCC), Madrid.
authors: E
authors: E
authors: Castro
authors: OncoMIR Training Program, Spanish National Cancer Research Centre (CNIO), Madrid; Medical Oncology Department, Hopsital Universitario de Salamanca, Salamanca, Spain.
authors: R
authors: R
authors: Lozano
authors: Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid; Centro Integral Oncológico Clara Campal (CIOCC), Madrid. Electronic address: dolmos@cnio.es.
authors: D
authors: D
authors: Olmos
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology*; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary*; D006801:Humans; D008214:Lymphocytes / Q000473:pathology*; D008297:Male; D009504:Neutrophils / Q000473:pathology*; D017430:Prostate-Specific Antigen / Q000097:blood*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000401:mortality* / Q000473:pathology*
chemical_list: D000305:Adrenal Cortex Hormones; D017430:Prostate-Specific Antigen